DNA cannot be patented: ruling
“A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated but cDNA is patent eligible,” the court ruled last week.
Nine justices reviewed a 2012 appeals court decision that allowed biotechnology company, Myriad Genetics Inc, to patent the BRCA1 and BRCA2 genes.
Associations representing 150,000 researchers, doctors and patients said the decision stopped them from doing research with the patented genes.
“The court struck down a major barrier to